Atropos Health

Another publication with real-world evidence (RWE) generated from Atropos Health. "Inflammatory vaginitis in women with multiple sclerosis: a retrospective analysis of B-cell depleting therapy compared to other disease modifying therapies" was published in "Multiple Sclerosis and Related Disorders." The paper explores the use of major B cell therapies for Multiple Sclerosis (e.g. rituximab, ocrelizumab, ofatumumab) and the risk of vaginitis in women with MS. Co-authors Sarah Esther Conway, MD, Gavin Hui, MD, Will Pike, MD, Cory Dodson, and Kristin Galetta. Access the full paper: https://lnkd.in/etS5_tsZ #RealWorldEvidence #RWE #AtroposHealth #MultipleSclerosis #BCellDepletingTherapy #DiseaseModifyingTherapies #BCellTherapies #Rituximab #Ocrelizumab #Ofatumumab #Vaginitis

Catch the live ChatRWD™ demonstration today Tuesday 10/22/24 at #HLTHUSA 2024 on the Newsroom stage (#5046) at 3:30PM PT. Today's presentation by Neil Sanghavi, President of Atropos Health, follows the press release announcing the results of the successful beta program and now the release of ChatRWD. ChatRWD (Chat Real World Data) reduces the time to produce high-quality publication-grade real-world evidence from months to minutes through a chat-based AI co-pilot. Today’s release allows clinicians from health systems and life sciences organizations to set-up an account and ask two clinical questions at no charge. Read more: https://hubs.li/Q02VkpzT0 #AtroposHealth #RWD #RealWorldData #RealWorldEvidence #RWE #HealthcareAI #AIinhealthcare #Healthtech

ChatRWD™ is now available to clinicians and researchers seeking to generate personalized real-world evidence for care in minutes. Today, Atropos Health announced the release of ChatRWD, the industry's first application incorporating chat-to-database capability and agents to help healthcare leaders advance and accelerate evidence generation rapidly, saving organizations valuable time, money, and resources. ChatRWD™ reduces the time to produce high-quality publication-grade real-world evidence from months to minutes through a chat-based AI co-pilot. Come see a live demo today at #HLTHUSA 2024 on the Newsroom stage (#5046) 3:30PM PT by Neil Sanghavi, President of Atropos Health. The demonstration will highlight the not only the technical achievements but also the user feedback during the beta program which led to today’s release. ChatRWD provides a unique vertical user experience and questions are answered with data from the Atropos Evidence™ Network, the largest federated data network with over 300 million patient records. Every answer comes with a Real World Fitness Score™ (RWFS) - evaluating the “fit-for-purpose” of the dataset used to answer the question. The average RWFS score across the questions in the evaluation was 79.8, indicating high quality data. Today’s release allows clinicians from health systems and life sciences organizations to set-up an account and ask two clinical questions at no charge. Read more from today's press release:https://hubs.li/Q02Vhc380 #HLTHUSA #AtropsHealth #ChatRWD #RealWorldEvidence #RWE #RealWorldData #RWD #GenerativeAI #AIinHealthcare #HealthcareAI

Don't miss this live demonstration of ChatRWD on the Newsroom stage (booth 5046) on Tuesday 10/22/24 at 3:30PM PT at #HLTHUSA #AtropsHealth #ChatRWD #RealWorldEvidence #RWE #RealWorldData #RWD

You don't want to miss this at #HLTHUSA! #AtroposHealth President Neil Sanghavi will be on the Newsroom stage #5046 on Tuesday 10/22/24 at 3:30PM PT for a live ChatRWD™ demo. ChatRWD is healthcare’s first chat-based AI application built for healthcare that generates real-world evidence in just minutes. With the rapid growth in GenAI applications, healthcare is quickly adopting these tools. The question is: Are publicly available LLMs and other widely used and easily accessible tools safe for clinical decision making? Come hear about ChatRWD and how being purpose-built for healthcare makes a difference. Atropos Health Chief Medical Officer and co-founder Dr. Saurabh Gombar spoke to Newsweek about this topic earlier. Read more here: https://hubs.li/Q02V4Gky0 #HLTHUSA #AtropsHealth #ChatRWD #RealWorldEvidence #RWE #RealWorldData #RWD #GenerativeAI #AIinHealthcare #HealthcareAI

Atropos Health is here in Las Vegas for day one of HLTHUSA. The team is here to talk about how Atropos Health delivers evidence to healthcare leaders just in time to make critical decisions in both research and care delivery settings. We bring real world evidence to both the bench and bedside with our evidence generating user experiences and real world data solutions, designed for life sciences and health system organizations looking to make clinical decisions based on evidence. Book a meeting with our team on the HLTH app or you can meet our team at the Newsroom stage (#5046) on Tuesday 10/22 at 3:30PM PT for an announcement. For a preview of our announcement, checkout https://hubs.li/Q02V1j910 #HLTHUSA #AtropsHealth #ChatRWD #RealWorldEvidence #RWE #RealWorldData #RWD

The "Utilization of High-Sensitivity C-Reactive Protein Testing in Primary and Secondary ASCVD Prevention" poster was presented at the Cardiometabolic Health Congress in Boston, MA this week from the teams at Atropos Health and Tourmaline Bio. Poster authors: Emil deGoma, MD, Yung Chyung, MD, John Walsh, MD, Will Pike, MD, Jananee Muralidharan, MD, Vinny Marino, J. Craig Davis, Saurabh Gombar MD, PhD, and Michael D. Shapiro, DO, MCR. For more information: https://hubs.li/Q02TZRHp0 #Cardiology #Health #Healthcare #Medical #CMHC19thAnnual #RWE #RealworldEvidence #RWD #RealworldData #AtroposHealth

As a 100% remote company, when the Atropos Health team has an opportunity to gather, it becomes a valuable occasion to engage face-to-face, fostering stronger interpersonal connections among team members who usually interact through screens. The meeting in Nashville was a great way to reconnect in person. #AtroposHealth https://hubs.li/Q02TWBhq0

#AtroposHealth is headed to HLTH 2024! Looking forward to connecting in-person with fellow healthtech innovators and changemakers. Our team will be talking about Real World Evidence and Artificial Intelligence (AI) built for healthcare. To learn more about us ahead of the show: https://hubs.li/Q02TDtN30 #HLTHUSA #RWE #RealWorldEvidence #HealthcareAI #AIinhealthcare #AtroposHealth #healthtech

In the world of high-stakes clinical decisionmaking and drug discovery and development, the evidence gap can be bridged by real-world data. Atropos Health President Neil Sanghavi speaks with Andrew Parambath from Pear VC on the Pear Healthcare Playbook, to share his perspective on innovation in healthtech, the role of healthcare data, and Atropos Health's growth strategy, go-to-market approach, the creation of ChatRWD™ healthcare's first AI-powered chat-to-database application, and the critical importance of data quality. To learn more about how high-quality, personalized evidence will transform healthcare, check out the podcast and article: https://hubs.li/Q02SJnbR0 #ClinicalData #AtroposHealth #DataDrivenDecisions #RealWorldEvidence #RWE #RWD #HealthcareAI #GenerativeAI #AIinhealthcare